✨ Free AI Report
Allurion Technologies, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Allurion Technologies, Inc.
Research Preview

Allurion Technologies, Inc.: Business Overview, Financials & Competitive Analysis

Allurion Technologies focuses on ending obesity with a weight loss platform offering the Allurion Program—a swallowable, procedure-less intragastric balloon—and AI-powered remote patient monitoring tools through its A...

Analyst-debate audio for Allurion Technologies, Inc.

AskCyborg analysts argue the bull and bear cases for Allurion Technologies, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Allurion Technologies, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
3/ 10Challenged

Cyborg Score thesis

Chardan Capital upgraded Allurion from Neutral to Buy on February 24, 2026, following FDA approval and strategic partnerships,...

Read the full analyst-debate transcript →
Industry Medical Devices & Digital Health - Obesity/Weight Loss Treatment
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Allurion Technologies, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Allurion Technologies, Inc. Overview

Pro stress-test →

Allurion Technologies focuses on ending obesity with a weight loss platform offering the Allurion Program—a swallowable, procedure-less intragastric balloon—and AI-powered remote patient monitoring tools through its Allurion Virtual Care Suite. The company achieved FDA premarket approval on February 23, 2026 for the Allurion Gastric Balloon System featuring the Allurion Smart Capsule.

Strategic Profile

Pro stress-test →

The Smart Capsule is a non-surgical, 15-minute orally administered device that resides approximately 4 months in the stomach and targets adults with BMI 30-40, opening access to approximately 80 million Americans with obesity. The company is pursuing strategic partnerships for expansion in Latin American markets, including a partnership with Bionut in Argentina that integrates cutting-edge weight loss methods like the Smart Capsule.

Competitive Landscape

Pro stress-test →

Allurion competes in the weight loss device and digital health market with its non-surgical balloon platform and AI-powered virtual care suite. Direct competitors include traditional bariatric surgery providers, GLP-1 medication manufacturers (Novo Nordisk's Mounjaro/tirzepatide), and other device makers. Allurion's differentiation lies in its procedure-less, swallowable approach combined with combination therapy strategies using lower-dose GLP-1 drugs.

Industry Context

Allurion Technologies, Inc. operates in Medical Devices & Digital Health - Obesity/Weight Loss Treatment.

Key facts

Founded: 2013 · Headquarters: Natick, Massachusetts, US · Revenue: $32.11M · Market cap: $14.37M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Allurion Technologies, Inc..

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Allurion Technologies, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Mounjaro/TirzepatideGLP-1 weight loss medication; used in combination with Allurion Smart Capsule→Traditional Bariatric SurgerySurgical weight loss alternative; invasive but with established long-term data→Ozempic/WegovyGLP-1 agonist for weight loss; medication-only approach without device→

Compare Allurion Technologies, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Allurion Technologies, Inc. operates in Medical Devices & Digital Health - Obesity/Weight Loss Treatment. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices & Digital Health - Obesity/Weight Loss Treatment research →
NEW · MCP server

Ask your AI assistant about Allurion Technologies, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Allurion Technologies, Inc. and its top competitor on Cyborg Score”
“What did Allurion Technologies, Inc. do this quarter?”
“Is Allurion Technologies, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Allurion Technologies, Inc. do?+
Allurion Technologies focuses on ending obesity with a weight loss platform offering the Allurion Program—a swallowable, procedure-less intragastric balloon—and AI-powered remote patient monitoring tools through its A...
What is Allurion Technologies, Inc.'s Cyborg Score?+
Allurion Technologies, Inc. has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Allurion Technologies, Inc.'s main competitors?+
Named competitors include Mounjaro/Tirzepatide, Traditional Bariatric Surgery, Ozempic/Wegovy. The full competitive landscape is in the AskCyborg report.
How can I get the full Allurion Technologies, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Allurion Technologies, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Allurion Technologies, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.